Jie Min Luo
Amministratore Delegato presso AMOY DIAGNOSTICS CO., LTD.
Posizioni attive di Jie Min Luo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Direttore/Membro del Consiglio | 13/08/2021 | - |
| Amministratore Delegato | 01/12/2021 | - | |
| Contatto Relazioni con gli Investitori | 18/06/2015 | - | |
| Segretario Aziendale | 18/06/2015 | 01/12/2021 | |
SinoPath Medical Investment (Beijing) Co., Ltd.
 SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jie Min Luo
Statistiche
Distribuzione geografica
| Cina | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
Settori
| Health Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
SinoPath Medical Investment (Beijing) Co., Ltd.
SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Health Services |
- Borsa valori
- Insiders
- Jie Min Luo
- Esperienza
